Bafna Pharma.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE878I01022
  • NSEID: BAFNAPH
  • BSEID: 532989
INR
284.40
-5.8 (-2.0%)
BSENSE

Aug 10, 03:16 PM

BSE+NSE Vol: 21.41 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 852453,
    "name": "Bafna Pharma.",
    "stock_name": "Bafna Pharma.",
    "full_name": "Bafna Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/bafna-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "284.40",
    "chg": -5.8,
    "chgp": "-2.0%",
    "dir": -1,
    "prev_price": "290.20",
    "mcapval": "687.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 532989,
    "symbol": "BAFNAPH",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE878I01022",
    "curr_date": "Aug 10, 03:16 PM",
    "curr_time": "15:18 PM",
    "last_traded_at": "Aug 10, 03:16 PM IST",
    "bse_nse_vol": "21.41 k",
    "exc_status": "Active",
    "traded_date": "Aug 10, 2026",
    "traded_date_str": "2026 08 10",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/bafna-pharma-852453-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Bafna Pharmaceuticals Ltd Hits New 52-Week High of Rs 296 on Back of Strong Technical Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-ltd-hits-new-52-week-high-at-rs296-4145540",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/BafnaPharmaceut_priceRelatedfactors_4145540.png",
        "date": "2026-08-10 10:37:36",
        "description": "From a 52-week low of Rs 85.24 to a fresh peak of Rs 296, Bafna Pharmaceuticals Ltd has surged an impressive 253.14% over the past year, outpacing the Sensex which declined by 1.60% in the same period. This remarkable rally culminated in the stock hitting a new all-time high today, buoyed by a confluence of bullish technical indicators and sustained price momentum."
      },
      {
        "title": "Bafna Pharmaceuticals Ltd Hits New 52-Week High of Rs 289 on Back of Strong Technical Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-ltd-hits-new-52-week-high-of-rs289-4141873",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/BafnaPharmaceut_priceRelatedfactors_4141873.png",
        "date": "2026-08-07 11:36:54",
        "description": "From a 52-week low of Rs 77.01 to a fresh peak of Rs 289, Bafna Pharmaceuticals Ltd has surged over 257% in the past year, significantly outpacing the Sensex's decline of 2.54%. This remarkable rally culminated in a new 52-week high on 7 Aug 2026, fuelled by a confluence of bullish technical indicators and sustained price momentum."
      },
      {
        "title": "When is the next results date for Bafna Pharmaceuticals Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-bafna-pharmaceuticals-ltd-4140623",
        "imagepath": "",
        "date": "2026-08-06 23:20:02",
        "description": "The next results date for Bafna Pharmaceuticals Ltd is scheduled for 11 August 2026...."
      },
      {
        "title": "Bafna Pharmaceuticals Ltd Hits New 52-Week High of Rs 285 on Back of Strong Technical Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-ltd-hits-new-52-week-high-at-rs285-4140107",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/BafnaPharmaceut_priceRelatedfactors_4140107.png",
        "date": "2026-08-06 11:36:01",
        "description": "From a 52-week low of Rs 77.01 to a fresh peak of Rs 285, Bafna Pharmaceuticals Ltd has surged an impressive 233.61% over the past year, significantly outpacing the Sensex’s decline of 2.12%. This remarkable rally culminated in a new 52-week high on 6 Aug 2026, fuelled by a confluence of bullish technical indicators and sustained price momentum."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Bafna Pharmaceuticals Ltd to 52-Week High of Rs 284.15",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-ltd-hits-new-52-week-high-at-rs28415-4137999",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/BafnaPharmaceut_priceRelatedfactors_4137999.png",
        "date": "2026-08-05 10:36:34",
        "description": "Surging to a new 52-week high of Rs 284.15 on 5 Aug 2026, Bafna Pharmaceuticals Ltd has demonstrated remarkable price momentum, outperforming its sector and the broader market with a 235.91% gain over the past year against the Sensex's decline of 2.57%."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Bafna Pharmaceuticals Ltd to 52-Week High of Rs 278",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-ltd-hits-new-52-week-high-at-rs278-4135532",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/BafnaPharmaceut_priceRelatedfactors_4135532.png",
        "date": "2026-08-04 10:37:35",
        "description": "Surging to a new 52-week high of Rs 278 on 4 Aug 2026, Bafna Pharmaceuticals Ltd has demonstrated remarkable price momentum, outperforming its sector and the broader market with a sustained rally that has extended over 11 consecutive trading sessions."
      },
      {
        "title": "Bafna Pharmaceuticals Ltd Hits New 52-Week High of Rs 273.15 on Back of Strong Technical Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-ltd-hits-new-52-week-high-at-rs27315-4133693",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/BafnaPharmaceut_priceRelatedfactors_4133693.png",
        "date": "2026-08-03 10:36:11",
        "description": "Surging past its previous peaks, Bafna Pharmaceuticals Ltd reached a fresh 52-week high of Rs 273.15 on 3 Aug 2026, marking a remarkable rally of 219.59% over the past year against the Sensex’s decline of 2.38%. This milestone caps a sustained momentum phase, with the stock gaining for ten consecutive sessions and outperforming its sector by 1.59% on the day."
      },
      {
        "title": "Bafna Pharmaceuticals Gains 9.31%: 6 Key Factors Driving the Rally",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-gains-931-6-key-factors-driving-the-rally-4131650",
        "imagepath": "",
        "date": "2026-08-01 15:02:44",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>27 Jul:</strong> New 52-week high at Rs.248.80</p>\n                    <p><strong>28 Jul:</strong> Further 52-week high at Rs.253.75</p>\n                    <p><strong>29 Jul:</strong> New 52-week high at Rs.258.80</p>\n                    <p><strong>30 Jul:</strong> 52-week high extended to Rs.263.95; valuation shifts noted</p>\n                    <p><strong>31 Jul:</strong> Week closes with new 52-week high at Rs.269.20</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.245.00</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">W..."
      },
      {
        "title": "Bafna Pharmaceuticals Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bafna-pharmaceuticals-ltd-is-rated-sell-4131268",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/BafnaPharmaceut_mojoScore_4131268.png",
        "date": "2026-08-01 10:10:04",
        "description": "Bafna Pharmaceuticals Ltd is currently rated 'Sell' by MarketsMOJO, with this rating last updated on 25 May 2026. However, the analysis and financial metrics discussed here reflect the stock's present position as of 01 August 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance."
      }
    ],
    "total": 370,
    "sid": "852453",
    "stock_news_url": "https://www.marketsmojo.com/news/bafna-pharmaceuticals-852453"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Meeting Scheduled On August 11 2026",
      "datetime": "05-Aug-2026",
      "details": "Bafna Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 inter alia to consider and approve the Un-Audited Financial Results for the Quarter ended June 30 2026",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "09-Jul-2026",
      "details": "Certificate under Regulation 74(5) of SEBI (DP) Regulations 2018 for the quarter ended June 30 2026.",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "26-Jun-2026",
      "details": "Intimation for Closure of Trading Window",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "11 Aug 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Bafna Pharmaceuticals Ltd has declared <strong>6%</strong> dividend, ex-date: 19 Sep 13",
          "dt": "2013-09-19",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Board Meeting Intimation for Meeting Scheduled On August 11 2026

05-Aug-2026 | Source : BSE

Bafna Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 inter alia to consider and approve the Un-Audited Financial Results for the Quarter ended June 30 2026

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

09-Jul-2026 | Source : BSE

Certificate under Regulation 74(5) of SEBI (DP) Regulations 2018 for the quarter ended June 30 2026.

Closure of Trading Window

26-Jun-2026 | Source : BSE

Intimation for Closure of Trading Window

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

11 Aug 2026

stock-summary
DIVIDEND

Bafna Pharmaceuticals Ltd has declared 6% dividend, ex-date: 19 Sep 13

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available